Saturday - March 14, 2026

HER2-Negative Metastatic Breast Cancer Pipeline Insight, 2025: Immunotherapy and ADCs Drive Innovation Across HR+ and TNBC Subtypes | DelveInsight

HER2-Negative Metastatic Breast Cancer Pipeline The HER2-negative metastatic breast cancer (MBC) landscape is rapidly evolving, with over 50 candidates in clinical development across hormone receptor-positive (HR+) and triple-negative breast cancer (TNBC) subtypes. Novel approaches—including antibody-drug conjugates (ADCs), immune checkpoint inhibitors, … Continue reading

Central Retinal Vein Occlusion Pipeline Insight 2025: Emerging Therapies Targeting Vision Preservation and Vascular Recovery | DelveInsight

Central Retinal Vein Occlusion Pipeline Insight The Central Retinal Vein Occlusion (CRVO) treatment landscape is advancing, with several companies developing novel therapies to improve outcomes. CRVO, caused by vein blockage in the retina, leads to vision loss, especially in older … Continue reading

Alfa Chemistry Enhances Textile Testing Services to Guarantee Compliance and Quality in International Markets

Alfa Chemistry expands its textile testing services, offering advanced analytical solutions for fabric, clothing, and functional textiles. These services help manufacturers meet global standards and ensure consumer safety. New York, USA – Alfa Chemistry, a globally recognized analytical testing company, … Continue reading